Recursion CFO Sells $26,970 in Shares as Stock Hovers Near 52-Week Low
Recursion Pharmaceuticals Chief Financial Officer Ben R Taylor sold 7,956 shares of Class A common stock on March 17, 2026, raising roughly $26,970 at $3.39 per share under a Rule 10b5-1 trading plan. The transaction occurred while the stock traded close to its 52-week low, and follows a net settlement of restricted stock units the previous day. Re…